Le Lézard
Classified in: Health

Discovery Health Partners welcomes Andrew Blackmon as new Chief Revenue Officer


ITASCA, Ill., July 18, 2018 /PRNewswire-PRWeb/ -- Discovery Health Partners today announced that Andrew Blackmon has joined the company as its new Chief Revenue Officer.

As Discovery's CRO, Andrew is responsible for cultivating successful, long-term relationships with US healthcare payers and helping to solve their challenges around revenue optimization, payment integrity and complying with regulatory changes.

Throughout his career of over 20 years, Andrew has developed a passion for leveraging technology-centric solutions that improve healthcare administration and transform the healthcare ecosystem. He comes to Discovery from xG Health Solutions, a spin-out of Geisinger Health, where he served as Chief, Sales and Business Development. Prior to xG, Andrew led the Population Health and Risk Management sales team at McKesson via its acquisition of MedVentive.

"We are very excited to welcome Andrew to the team," Jason Brown, Discovery CEO, commented. "His vision for how technology-powered solutions can improve the healthcare payer space is very well aligned with Discovery's overall mission."

"Andrew brings tremendous industry knowledge and a track record of building superior relationships with prospects and clients," added Steve Unterberger, Managing Director at Carrick Capital Partners and a member of Discovery's Board. "We have the highest confidence that Andrew will play a key role in Discovery's continued growth and in enhancing our value to clients with our continually expanding solution portfolio."

About Discovery Health Partners
Discovery Health Partners' mission is to deliver unique, actionable analytic insights and technology-powered solutions to help healthcare payers improve payment integrity, increase revenue optimization, and maximize efficiencies with government programs. For more information, go to https://www.DiscoveryHealthPartners.com.

SOURCE Discovery Health Partners


These press releases may also interest you

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....

at 07:10
908 Devices Inc. , a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will...

at 07:10
Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip...

at 07:10
ZYUS Life Sciences Corporation (the "Company") , a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announced today that the USPTO...

at 07:10
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of...

at 07:05
hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today announced preclinical data supporting its lead program in severe hemophilia A at the World...



News published on and distributed by: